Research funder · United States
BrightFocus Foundation
Non-profit organization in the USA
- Grants since 2016
- 717
- Awarded, last 5 years (where amounts are published)
- $108M
- Funded works, last 5 years
- 1 862
- Funded works, all time
- 3 290
Grants
2025–2028 · research · Macular Degeneration Research: Standard
Realtime monitoring of the expression of AMD risk genes TLE2 and FRZB in retinal pigment epithelium in vivo
Jerzy Szablowski · Rice University
2025–2028 · research · Alzheimer's Disease Research: Standard
Genetic determinants of progression in Alzheimer's disease using Placebo arm of Randomised Control Trial data
John Hardy · University College London
2025–2028 · research · Alzheimer's Disease Research: Standard
Investigating the role of immune cell exhaustion and gene-by-environment interactions in FTD
Rebecca Wallings · Indiana University
2025–2028 · research · Alzheimer's Disease Research: Standard
Does dysregulated biosynthesis of niacin in the gut contribute to Alzheimer's disease progression?
Miguel Moutinho · Indiana University
2025–2028 · research · Alzheimer's Disease Research: Standard
Promoting oligodendrogenesis with ultrasound for Alzheimer’s disease: A non-invasive, non-pharmacological regenerative strategy
Isabelle Aubert · Sunnybrook Research Institute
2025–2027 · research · National Glaucoma Research: Standard
The role of microglia-derived IL10 in a mouse model of glaucoma
Tatjana Jakobs · The Schepens Eye Research Institute, Mass. Eye And Ear
2025–2027 · research · Macular Degeneration Research: Standard
Investigating the role of complement C3a receptor signaling in STAT3-mediated RPE dysfunction
Valencia Fernandes · University of California, San Francisco
2025–2027 · research · National Glaucoma Research: Standard
Harnessing Artificial Intelligence to Enhance the Access and Equity of Glaucoma Care
Benjamin Xu · University of Southern California
2025–2026 · research · BrightFocus Foundation: Standard
Regulatory mechanisms underlying endosomal targeting of SORL1
Olav Andersen · Max Delbrück Center
2025–2027 · research · Alzheimer's Disease Research: Standard
Structural diversity of amyloid deposits in Alzheimer disease
Anllely Fernandez · Indiana University
2025–2028 · research · Macular Degeneration Research: Standard
Leveraging genetics and pigmentation to discover mechanism drusen formation – a hallmark of AMD pathology
Ruchi Sharma · National Eye Institute
2025–2028 · research · Alzheimer's Disease Research: Standard
Identifying TDP-43 pathology burden in a mixed cohort of aging brains
Jack Humphrey · Icahn School of Medicine at Mount Sinai
2025–2027 · research · Alzheimer's Disease Research: Standard
The astrocyte cell surface proteome in Alzheimer’s Disease
Omar Peña-Ramos · Baylor College of Medicine
2025–2028 · research · Alzheimer's Disease Research: Standard
Uncovering the role of PLCG2 and its variants in Alzheimer’s disease
Hongjun Fu · The Ohio State University
2025–2026 · research · BrightFocus Foundation: Standard
CARE Consortium Biobank
Thomas Mcallister · Indiana University
2025–2027 · research · Alzheimer's Disease Research: Standard
Personalized proteomics to decipher cognitive heterogeneity and advance AD prognosis
Federica Anastasi · Barcelonaβeta Brain Research Center
2025–2028 · research · Alzheimer's Disease Research: Standard
Investigating the processing of Amyloid Precursor Protein via the eta-secretase pathway in healthy aging and Alzheimer’s disease
Justyna Dobrowolska Zakaria · Northwestern University
2025–2028 · research · Alzheimer's Disease Research: Standard
Focused Ultrasound-Mediated Microglial Activation to Promote Amyloid Beta Clearance in Alzheimer’s Disease
Nader Saffari · University College London
2025–2027 · research · National Glaucoma Research: Standard
The cumulative role of repeated IOP elevations in epigenetic reprogramming and aging.
Dorota Skowronska-Krawczyk · University of California, Irvine
2025–2028 · research · Alzheimer's Disease Research: Standard
Female specific life course risk factors for AD: Interactions of pregnancy and menopause
Damian Zuloaga · University at Albany, State University of New York
2025–2027 · research · Macular Degeneration Research: Standard
Heparan Sulfate Regulation of HTRA1-Mediated Proteostasis in Bruch's Membrane in Age-Related Macular Degeneration
Jaesoo Jung · University of California San Diego
2025–2027 · research · National Glaucoma Research: Standard
Assessment of Vascular Resistance in Glaucoma
Brad Fortune · Legacy Health
2025–2028 · research · Macular Degeneration Research: Standard
The role of macrophages/microglia in retinal pigmented epithelium function with aging and Western diet
Ana Chucair-Elliott · University of Oklahoma Health Sciences Center
2025–2027 · research · National Glaucoma Research: Standard
Transgene expression of Stanniocalcin-1 for sustained intraocular pressure reduction and a reduced side effect profile in a large animal model
Gavin Roddy · Mayo Clinic
2025–2027 · research · Alzheimer's Disease Research: Standard
CXCR3 chemokine receptor blockade as a therapy for CNS T-cell infiltration in tauopathy and neurodegeneration
Joshua Emmerson · Washington University in St. Louis
2025–2028 · research · Alzheimer's Disease Research: Standard
A sleeping pill for Alzheimer’s disease
Ksenia Kastanenka · Massachusetts General Hospital
2025–2026 · research · BrightFocus Foundation: Standard
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Mallar Chakravarty · Douglas Mental Health University Institute
2025–2027 · research · National Glaucoma Research: Standard
Molecular basis for Angptl7 in steroid-induced ocular hypertension
W. Daniel Stamer · Duke University
2025–2027 · research · Alzheimer's Disease Research: Standard
Leveraging humanised microglia models to unravel C9orf72 gain and loss of function synergistic mechanisms in FTD
Laura Fumagalli · Vlaams Instituut voor Biotechnologie
2025–2028 · research · Alzheimer's Disease Research: Standard
Unraveling Cotton Wool Plaques in Alzheimer’s disease : An Integrated Genetics and Proteomics Approach
Cyril Pottier · Washington University in St. Louis
2025–2027 · research · Alzheimer's Disease Research: Standard
Dissecting the autonomous and non-autonomous cellular consequences of ABCA7 risk variants using stem cell models of Alzheimer’s disease
Sarah Heuer · Brigham and Women's Hospital
2025–2027 · research · Alzheimer's Disease Research: Standard
The role of DYRK1A in altered microglia biology in a cellular model of Alzheimer's disease in Down syndrome
Frances Wiseman · University College London
2025–2028 · research · Alzheimer's Disease Research: Standard
CHIP/STUB1: A New Frontier in Tau Chaperoning and Alzheimer's Disease Therapeutics
Todd Cohen · University of North Carolina at Chapel Hill
2025–2027 · research · Macular Degeneration Research: Standard
Microglial Regulation of Developing and Restored Cone Visual Circuits
Ashley Farre · University of Idaho
2025–2028 · research · Alzheimer's Disease Research: Standard
Mechanisms of myelin dysfunction in Alzheimer’s disease
Katerina Akassoglou · Gladstone Institutes
2025–2028 · research · Macular Degeneration Research: Standard
Extended Drug Delivery with Spatial Guidance to Neovascular Membranes in Age-Related Macular Degeneration
Charles Deboer · Stanford University
2025–2027 · research · Alzheimer's Disease Research: Standard
Targeting LINE-1 to Resolve Neurogenic Inflammation in Alzheimer’s Disease
Joseph Herdy · Salk Institute for Biological Studies
2025–2027 · research · Alzheimer's Disease Research: Standard
Application of novel, stem-cell based approaches to study the mechanism of protective microglial response in Alzheimer’s Disease
Ghazaleh Eskandari-Sedighi · University of California, Irvine
2024–2026 · fellowship · National Glaucoma Research: Postdoctoral Fellowship
Eye-specific vulnerability to acute elevated IOP at axon level and its correlation with glaucomatous neural tissue loss
Bingrui Wang · University of Pittsburgh
2024–2026 · research · BrightFocus Foundation: Standard
High granularity immune phenotyping in ageing – towards molecular markers of declined immunity, chronic inflammation and neurodegenerative disease
Alon Monsonego · Ben-Gurion University of the Negev